Best Telehealth Clinics in Nevada (2026)

Nevada's telehealth framework is governed by NRS 629.515 (telehealth definitions and practice) and NRS 639.235 / NRS 639.23913 (controlled substance prescribing). A patient-provider relationship can be established via telehealth through an in-person, electronic, telephonic, or fiber optic examination within the prior six months.

Nevada does not require a mandatory in-person visit before prescribing controlled substances via telehealth, but the provider must have met the patient (in-person or via telehealth) within the preceding six months. For Schedule II through IV pain management specifically, the provider must reevaluate the patient before increasing dosages, and must review the treatment plan if the patient has used a controlled substance for 90 or more consecutive days.

Real-time audio-visual interaction is generally required for initial controlled substance prescriptions. Audio-only telephone encounters may not be sufficient for the initial prescribing visit. Follow-up consultations may use audio-only for established patients.

Nevada is an active IMLC member with SPL status. Out-of-state physicians can obtain expedited Nevada licensure through the compact. Combined with the state's permissive telehealth framework, Nevada is accessible for most national telehealth platforms.

Nevada is a full practice authority state for nurse practitioners. NPs can prescribe independently without physician oversight, including Schedule II through V controlled substances. This expands telehealth provider availability.

Nevada has no state income tax — one of nine states without one. This does not directly affect telehealth pricing but is relevant to residents' overall cost burden.

Nevada Medicaid does not cover GLP-1 receptor agonists for obesity. Coverage is limited to diabetes indications. The state has not enacted legislation to expand Medicaid GLP-1 coverage as of April 2026.

Nevada has 3.1 million residents. Provider availability is strong, supported by IMLC membership, full NP practice authority, and no separate in-person requirement for controlled substances. Most national telehealth platforms serve the state.

All major TRT providers serve Nevada. Maximus ($100/mo, all 50 states), Hone Health ($25/mo, all 50 states), TRT Nation ($99/mo, 45 states including NV), BraverX ($129/mo), PeterMD ($99/mo), DudeMeds ($77/mo), and Titan Medical ($99/mo) are available.

GLP-1 availability is unrestricted. Embody, SkinnyRx, DirectMeds, Zealthy, Remedy Meds, GobyMeds, Sesame Care, MEDVi, Shed, Sunlight, and Mochi Health all serve Nevada. No Medicaid GLP-1 obesity coverage.

All HRT, hair loss, and ED providers with national coverage serve Nevada. Midi Health accepts insurance. No known state-specific provider exclusions for NV.

TRT pricing from available providers: DudeMeds $77/mo ($1,124/year), TRT Nation $99/mo ($1,446/year), PeterMD $99/mo ($1,188/year), Maximus $100/mo ($1,300/year), BraverX $129/mo ($1,548/year), Defy Medical $200/mo ($2,800/year).

GLP-1 ranges from $99/mo to $399/mo. Median is $179/mo. Nevada Medicaid does not cover GLP-1s for obesity. Patients must pay out of pocket or use commercial insurance.

Nevada does not tax prescription medications. The state sales tax is 6.85% (plus local taxes up to 8.375% in Clark County) but Rx drugs are exempt. Nevada has no state income tax.

HRT: Midi Health (insurance), PlushCare ($20/mo), Evernow ($35/mo), Alloy ($49/mo). ED: Hims $17/mo to MEDVi $119/mo.

Las Vegas and Reno have higher costs of living than rural Nevada. Telehealth pricing is national and does not vary by metro area.

TRT (testosterone replacement therapy)

Nevada does not require a separate in-person visit for TRT if the provider has evaluated the patient via telehealth within the prior six months (NRS 629.515). Real-time audio-video required for initial prescription. Full NP practice authority supports provider availability. Both compounded and FDA-approved testosterone are available.

GLP-1 weight loss

No state-specific GLP-1 restrictions in Nevada. Federal FDA compounding rules apply. Nevada Medicaid does not cover GLP-1s for obesity.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Nevada. No additional state restrictions apply.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Nevada. No additional state restrictions apply.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Nevada. No additional state restrictions apply.

Peptides

Peptide therapy follows standard federal rules in Nevada. Full NP practice authority and IMLC membership support provider availability. Non-controlled peptides have fewer restrictions.